Class information for:
Level 1: K65R//TRANSMITTED DRUG RESISTANCE//HIV 1 DRUG RESISTANCE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1447 2561 33.9 82%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
26 34435 ANTIRETROVIRAL THERAPY//HIV//NEVIRAPINE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 K65R Author keyword 32 80% 1% 20
2 TRANSMITTED DRUG RESISTANCE Author keyword 29 59% 1% 32
3 HIV 1 DRUG RESISTANCE Author keyword 26 55% 1% 32
4 HIV DRUG RESISTANCE Author keyword 23 38% 2% 48
5 M184V Author keyword 21 75% 1% 15
6 REPLICATION CAPACITY Author keyword 16 53% 1% 21
7 DRUG RESISTANCE TESTING Author keyword 15 82% 0% 9
8 GENOTYPIC RESISTANCE TESTING Author keyword 15 77% 0% 10
9 VIRTUAL PHENOTYPE Author keyword 15 88% 0% 7
10 INT CLIN VIROL Address 13 67% 0% 12

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 K65R 32 80% 1% 20 Search K65R Search K65R
2 TRANSMITTED DRUG RESISTANCE 29 59% 1% 32 Search TRANSMITTED+DRUG+RESISTANCE Search TRANSMITTED+DRUG+RESISTANCE
3 HIV 1 DRUG RESISTANCE 26 55% 1% 32 Search HIV+1+DRUG+RESISTANCE Search HIV+1+DRUG+RESISTANCE
4 HIV DRUG RESISTANCE 23 38% 2% 48 Search HIV+DRUG+RESISTANCE Search HIV+DRUG+RESISTANCE
5 M184V 21 75% 1% 15 Search M184V Search M184V
6 REPLICATION CAPACITY 16 53% 1% 21 Search REPLICATION+CAPACITY Search REPLICATION+CAPACITY
7 DRUG RESISTANCE TESTING 15 82% 0% 9 Search DRUG+RESISTANCE+TESTING Search DRUG+RESISTANCE+TESTING
8 GENOTYPIC RESISTANCE TESTING 15 77% 0% 10 Search GENOTYPIC+RESISTANCE+TESTING Search GENOTYPIC+RESISTANCE+TESTING
9 VIRTUAL PHENOTYPE 15 88% 0% 7 Search VIRTUAL+PHENOTYPE Search VIRTUAL+PHENOTYPE
10 MINORITY VARIANTS 13 67% 0% 12 Search MINORITY+VARIANTS Search MINORITY+VARIANTS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 GENOTYPIC RESISTANCE 142 68% 5% 125
2 ZIDOVUDINE RESISTANCE 123 61% 5% 130
3 HIGH LEVEL RESISTANCE 88 33% 9% 223
4 VIRAL FITNESS 67 58% 3% 78
5 SOCIETY USA PANEL 49 28% 6% 146
6 VIRTUAL PHENOTYPE 41 85% 1% 22
7 CLEAVAGE SITE MUTATIONS 38 89% 1% 17
8 VIROLOGICAL FAILURE 36 22% 6% 148
9 VIRAL VARIANTS 34 69% 1% 29
10 POL GENE MUTATIONS 33 64% 1% 32

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure A Systematic Review and Pooled Analysis 2011 101 33 64%
Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel 2008 226 173 54%
Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an international AIDS Society-USA panel 2003 349 105 66%
Medical progress: HIV drug resistance 2004 384 91 52%
Temporal Changes in the Epidemiology of Transmission of Drug-Resistant HIV-1 across the World 2012 56 215 56%
HIV-1 drug resistance mutations: an updated framework for the second decade of HAART 2008 148 277 49%
HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: A view from the clinic and ex vivo 2008 83 166 74%
Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection 2007 72 68 76%
Antiretroviral Treatment of Adult HIV Infection 2010 Recommendations of the International AIDS Society-USA Panel 2010 467 107 9%
Evolutionary pathways of transmitted drug-resistant HIV-1 2011 26 62 77%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INT CLIN VIROL 13 67% 0.5% 12
2 VIROL IMMUNOL BIOL 7 53% 0.4% 9
3 CLIN GEN MED GASTROENTEROL INFECT DIS 6 71% 0.2% 5
4 HLTH CARE LIFE SCI GRP 6 100% 0.2% 4
5 RECH ANTIVIRALE 5 60% 0.2% 6
6 EA 4409 5 54% 0.3% 7
7 EA 2968 4 32% 0.4% 11
8 BIOMED PETERSPL 4 75% 0.1% 3
9 CLIN VIROL SURROGATES UNIT 4 75% 0.1% 3
10 DIRECT SOINS SANTE BASE 4 75% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000208697 AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1 SUBTYPES//CIRCULATING RECOMBINANT FORMS
2 0.0000205423 ROYAL FREE HIV MED//CD4 CELL COUNT//X BICHAT MED
3 0.0000200316 ETRAVIRINE//RILPIVIRINE//TMC125
4 0.0000139860 NNRTIS//REVERSE TRANSCRIPTASE//HIV 1 REVERSE TRANSCRIPTASE
5 0.0000120585 UNITE RETROVIROL MOL//ENTROPY EVOLUTION RATE//HIV 1 MOTHER TO CHILD TRANSMISSION
6 0.0000116363 ATAZANAVIR//RITONAVIR//LOPINAVIR
7 0.0000097624 HIV 1 PROTEASE//HIV PROTEASE//KNI 272
8 0.0000089587 HIV LATENCY//HIV CURE//HIV 1 LATENCY
9 0.0000078172 EPIDEMIOL PATHOPHYSIOL ONCOGEN VIRUS UNIT//LYSSAVIRUS DYNAM HOST AD TAT UNIT//VIRAL DISCOVERY
10 0.0000074136 LOSS TO FOLLOW UP//KNOWLEDGE TRANSLAT UNIT//HLTH ECON EPIDEMIOL OFF